Brio Bliss Life Science Private Limited

Brio Bliss Life Science Private Limited - pharma in Chennai, Tamil Nadu, India. Directors, charges & compliance details.
CIN U93000TN2012PTC087450 Incorporated 31 August 2012 ROC Chennai HQ Chennai, Tamil Nadu, India
Merged Private Limited Company pharma
Data last updated
Revenue · FY 2021
₹9.84 Cr
▼ 35% YoY
Net loss · FY 2021
₹12.42 Cr
Net margin -126.1%
EBITDA · FY 2021
-₹10.54 Cr
EBITDA margin -107.1%
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹3.82 Cr
Issued & subscribed
Satisfied charges
₹55.04 Lakh
No open charges
Company age
14 yrs
Est. 2012
Employees · EPFO
46
Provident fund records

About Brio Bliss Life Science Private Limited

Data last updated:

Brio Bliss Life Science Private Limited was a private limited company based in Chennai, Tamil Nadu, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 August 2012.

The company was registered with the Registrar of Companies (ROC), Chennai, under CIN U93000TN2012PTC087450. Its GSTIN is 33AAFCB1545B1ZD (Tamil Nadu). The company held 2 GST registrations, all of them active.

The company had an authorised share capital of ₹6 Cr and a paid-up capital of ₹3.82 Cr. It was led by directors including Jayaraman Skrishnan and Lakshmi Narasimhan Mahadevan.

Its last annual general meeting (AGM) was held on 19 October 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at S.No. 15/1 15/2 Vanagaram Service Road, Chennai, Tamil Nadu, India – 600095.

As per the financials filed for FY 2021, the company reported a revenue of ₹9.84 Cr, a decline of 35% compared to the previous year. For the same year it recorded a net loss of ₹12.42 Cr (net margin -126.1%) and EBITDA of -₹10.54 Cr (EBITDA margin -107.1%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 17% over five years.

The company had about 46 employees on its provident fund (EPFO) records before it was dissolved.

The company was associated with 1 brand: Brio Bliss Life Science. As per MCA filings, the company had satisfied charges of ₹55.04 Lakh on record. Court records list 5 cases involving the company, including 5 filed by the company. The company has 15 deals on record (7 funding rounds, 7 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹25.12 Cr; the latest was in March 2021. Its 3 peer companies in the Pharma industry (Formulations), with the same principal business activity (wholesale trading) are compared by revenue, 3 larger; the largest is Ventus Pharmaceuticals Private Limited with revenue of ₹9.89 Cr.

The last known website on record is briobliss.co.in.

Company details

CIN U93000TN2012PTC087450
Registration Number 087450
Incorporation Date 31 August 2012
ROC Chennai
Listing Status Unlisted
Company Status Amalgamated
Date of Last AGM 19 October 2021
Date of Balance Sheet 31 March 2021
Compliance Status Active Compliant

Contact details

Brio Bliss Life Science Private Limited's registered office is in Chennai, Tamil Nadu. Its website is briobliss.co.in. Its e-mail address is in the company report.

  • Email
  • Social Media
  • Registered Address
    S.No. 15/1 15/2 Vanagaram Service Road, Chennai, Tamil Nadu, India – 600095
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Brio Bliss Life Science Private Limited, buy the company report.

Comprehensive company report
Brio Bliss Life Science Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Brio Bliss Life Science operates one associated brand: Brio Bliss Life Science. Each brand links to its own profile.

BrandDescriptionWebsite
Formulations of phytochemicals, probiotics, and nutraceuticals are developed.briobliss.com

Business activity

The main business activity of Brio Bliss Life Science is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Brio Bliss Life Science Private Limited, buy the company report.

Financials of Brio Bliss Life Science Private Limited

FY 2021 filings available

Brio Bliss Life Science Private Limited reported revenue of ₹9.84 Cr (down 35% YoY) for FY 2021.

Revenue · FY 2021
₹9.84 Cr ▼ 35%
Net loss · FY 2021
₹12.42 Cr margin -126.1%
EBITDA · FY 2021
-₹10.54 Cr margin -107.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 35%
3 years · compounded
▼ 19%
5 years · compounded
▲ 17%
EBITDA CAGR growth
3 years · compounded
▼ 4%
5 years · compounded
▼ 21%

Revenue fell 35% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 17%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹10.54 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹12.42 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
EBITDA Margin-107.1%
Net Profit Margin-126.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Brio Bliss Life Science Private Limited, buy the company report.

Board of directors of Brio Bliss Life Science Private Limited

Brio Bliss Life Science has 5 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Ramnad Krishnan RamanathanAdditional Director15 Feb 20224 Years 8 MonthsAs last reported
Jayaraman SkrishnanDirector22 May 20179 Years 5 MonthsAs last reported
Lakshmi Narasimhan MahadevanDirector21 Mar 20197 Years 7 MonthsAs last reported
Ramani Kuppuswamy GaneshDirector30 Aug 201412 Years 2 MonthsAs last reported
Krishna Krishnan RamanathanDirector30 Aug 201412 Years 2 MonthsAs last reported

Peer comparison

Brio Bliss Life Science Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Ventus Pharmaceuticals Private Limited₹9.89 Cr (FY 2025)12.0%Panchkula, Haryana, India
Erweka (India) Private Limited₹9.88 Cr (FY 2025)43.0%Ahmedabad, Gujarat, India
Medilloyd Medicament Private Limited₹9.88 Cr (FY 2020)11.0%Cuttack, Odisha, India
Brio Bliss Life Science Private Limitedthis company₹9.84 Cr (FY 2021)-₹12.42 Cr-126.1%-35.0%46Chennai, Tamil Nadu, India

To see the full peer comparison of Brio Bliss Life Science Private Limited, buy the company report.

Auditor

Brio Bliss Life Science Private Limited is audited by AR ANNAMALAI & CO for the financial year 2020.

Auditor firmFinancial yearFirm registration number
AR ANNAMALAI & COFY 2020000207S

Shareholding

The shareholding of Brio Bliss Life Science Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Brio Bliss Life Science Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹55.04 Lakh
Breakdown by lending institutions
Punjab National Bank₹0.50 Cr
Others₹0.05 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
21 Aug 2017100169228Others₹5.04 LakhSatisfied
25 Feb 201310407229Punjab National Bank₹50 LakhSatisfied

To see the full charge records of Brio Bliss Life Science Private Limited, buy the company report.

Total charge records: 2 View all charges

Deals & funding

Brio Bliss Life Science Private Limited has 15 deals on record (7 funding rounds, 7 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹25.12 Cr; the latest was in March 2021.

Total deals
15
Funding rounds
7
Secondary share transfers
7
Convertible or debt financing
1
Disclosed funding
₹25.12 Cr

Deals on record (5 of 15)

WhenDealAmountParties
Mar 2021Secondary share transferUndisclosedBuyer: Shield Health Care Private Limited , 3 individuals
Seller: Fulcrum Private Equity, 3 individuals
Mar 2020Funding round₹3.93 CrInvestors: Fulcrum Private Equity
Mar 2020Funding round₹13.4 LakhInvestors: Fulcrum Private Equity
Mar 2020Secondary share transferUndisclosedBuyer: 2 individuals
Seller: Fulcrum Private Equity
Mar 2017Funding round₹7.9 CrInvestors: Accounts Receivables Management Services (India) Private Limited, 3 individuals

To see the full deal history of Brio Bliss Life Science Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Brio Bliss Life Science Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Brio Bliss Life Science Private Limited has a workforce of 46 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.

Employee count
46
Active EPFO establishments
1
Employee growth
-6.12%

GST

Brio Bliss Life Science has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
33AAFCB1545B1ZDTamil NaduActive01 Jul 2017
24AAFCB1545B1ZCGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Brio Bliss Life Science Private Limited, buy the company report.

Recent activity

Brio Bliss Life Science Private Limited has 14 board changes on record since 2014: 5 appointments and 9 cessations. The latest: Hariharasubramanian Swaminathan ceased to be Director on 29 Mar 2022.

Ceased
Hariharasubramanian Swaminathan ceased to be Director.
Ceased
Vajjala Anantharamana ceased to be Director.
Ceased
Satyanarayan Ramanathan ceased to be Managing Director.
Appointed
Ramnad Krishnan Ramanathan was appointed as Additional Director.
Charges
A charge registered on 21 Aug 2017 via Charge ID 100169228 with Others was fully satisfied on 22 Nov 2021.
Charges
A charge registered on 25 Feb 2013 via Charge ID 10407229 with Punjab National Bank was fully satisfied on 22 Nov 2021.
AGM
Brio Bliss Life Science Private Limited last Annual general meeting of members was held on 19 Oct 2021 as per latest MCA records.
Ceased
Subbaraaman Vikram Harid ceased to be Director.
Ceased
Susmitha Laggishetty ceased to be Director.
Filing
Brio Bliss Life Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Chennai.
Ceased
Lakshmi Narasimhan Mahadevan ceased to be Additional Director.
Appointed
Lakshmi Narasimhan Mahadevan was appointed as Director.

10 earlier events are in the company report.

Frequently asked questions

Brio Bliss Life Science has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.

Brio Bliss Life Science was a private limited company based in Chennai, Tamil Nadu, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 31 August 2012 and is registered under CIN U93000TN2012PTC087450. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.

Brio Bliss Life Science was incorporated on 31 August 2012. It is registered with the Registrar of Companies, Chennai.

Brio Bliss Life Science had 5 directors:

The CIN (Corporate Identification Number) of Brio Bliss Life Science is U93000TN2012PTC087450. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Brio Bliss Life Science is at S.No. 151 152 Vanagaram Service Road, Chennai, Tamil Nadu, India – 600095.

Brio Bliss Life Science can be reached through the website briobliss.co.in. Its registered office is in Chennai, Tamil Nadu, India.

The latest financial statements of Brio Bliss Life Science on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 19 October 2021. Year-wise statements from 2015 are in the company report.

The GSTIN of Brio Bliss Life Science is 33AAFCB1545B1ZD, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAFCB1545B1ZC (Gujarat).

Brio Bliss Life Science operated in the pharma industry, in the drug formulation and development segment.

Brio Bliss Life Science has 15 deals on record (7 funding rounds, 7 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹25.12 Cr; the latest was in March 2021.